Two Sigma Securities’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Two Sigma Securities’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.8K	Buy	60,102 +42,480	+241%	+$16.9K	﹤0.01%	1422
2025 Q4	$7.4K	Sell	17,622 -47,690	-73%	-$25.3K	﹤0.01%	1317
2025 Q3	$44K	Buy	+65,312	New	+$35.2K	0.01%	1007
2020 Q1	–	Sell	-16,528	Closed	-$138K	–	2184
2019 Q4	$138K	Buy	+16,528	New	+$152K	﹤0.01%	2166
2019 Q3	–	Sell	-16,471	Closed	-$177K	–	2413
2019 Q2	$177K	Buy	+16,471	New	+$175K	﹤0.01%	1767
2017 Q1	–	Sell	-21,733	Closed	-$66K	–	1093
2016 Q4	$66K	Buy	+21,733	New	+$79.1K	0.02%	587

Other funds holding SGMO

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Two Sigma Securities's SGMO Position: Q1 2026 in Review

Two Sigma Securities increased its SANGAMO THERAPEUTICS INC (SGMO) stake by 241% in Q1 2026, buying an estimated $16.9K and bringing the position to 60,102 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1422.

Two Sigma Securities first reported a position in SGMO in Q4 2016 and has held it in 6 quarters since. The position peaked at $177K in Q2 2019. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

Two Sigma Securities held 60,102 shares of SANGAMO THERAPEUTICS INC worth $14.8K as of Q1 2026.
Two Sigma Securities bought 42,480 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $16.9K.
SANGAMO THERAPEUTICS INC made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1422 holding.
Two Sigma Securities first reported a position in SANGAMO THERAPEUTICS INC in Q4 2016 and has held it in 6 quarters since.
Two Sigma Securities's SANGAMO THERAPEUTICS INC position peaked at $177K in Q2 2019.
112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.